A 58-year-old with type 2 diabetes and CKD asks about SGLT2 initiation (eGFR 24). Which statement is correct?...

Question

A 58-year-old with type 2 diabetes and CKD asks about SGLT2 initiation (eGFR 24). Which statement is correct?

Accepted Answer

SGLT2 inhibitors are recommended at eGFR ≥20 mL/min/1.73 m² to reduce CKD and CV events

Answer

SGLT2 inhibitors require eGFR ≥60

Answer

SGLT2s are contraindicated in CKD

Answer

SGLT2s increase hyperkalemia and should be avoided with ACEi

Answer

SGLT2s are for glycemic control only without renal benefits

us-abfm MCQ (SBA): SGLT2 Use in CKD